Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
142 participants
INTERVENTIONAL
2003-11-30
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Fermented milk
Fermented milk
Formula used for non breastfed children or in complement of breastfeeding
2
Standard milk
Standard milk
Formula used for non breastfed children or in complement of breastfeeding
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fermented milk
Formula used for non breastfed children or in complement of breastfeeding
Standard milk
Formula used for non breastfed children or in complement of breastfeeding
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mother agreeing to stop consumption of yogurts and fermented milks during the 3rd quarter of pregnancy
* mother agreeing to receive a calcium supplementation during the 3rd quarter of pregnancy
* atopic mother or father and at least another atopic member (sister or brother)
* parents having given written informed consent
* adhesion to eviction regimen for mother and child
* parents agreeing with a regular follow-up (3 visits and monthly phone call with the dietician)
Exclusion Criteria
* parents refusing to sign the informed consent
* infant in a situation which could interfere with an optimal participation to the study, or which could represent a risk for the infant, according to the investigator
* known or suspected immunodeficiency in the family
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optimed Medizinische Instrumente GmbH
INDUSTRY
Bledina
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bledina
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christophe Dupont, PhD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Saint Vincent de Paul
Denise-Anne Moneret-Vautrin, PhD
Role: PRINCIPAL_INVESTIGATOR
Hôpital central
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital central
Nancy, , France
Hôpital Saint Vincent de Paul
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BL006
Identifier Type: -
Identifier Source: org_study_id